In den Warenkorb
Bestellen Sie auch über:
![]() |
+33 (0)1 76 63 32 65 |
![]() |
+33 (0)1 74 18 08 22 |
Eph Receptor tyrosine Kinase A2 (EPHA2) Antikörper
| Antigen | Eph Receptor tyrosine Kinase A2 (EPHA2) |
| Klonalität | Monoklonal (Kalpha-5H5) |
| Wirt |
Maus |
| Reaktivität |
Human |
| Applikation |
Durchflusszytometrie (FACS), Zell-ELISA (cELISA), Immunfluoreszenz (IF)
|
![]() |
4 Publikationen vorhanden |
| Produktnummer | ABIN179724 |
| Menge | 100 ug (2 mg/ml) |
| Preis | 250,00 € Zzgl. Versandkosten €40,00 und MWSt |
| Lieferung nach |
|
| Verfügbarkeit | Lieferung in 3 bis 5 Werktagen |
Produktbeschreibung
| Weitere Bezeichnung | Eph receptor tyrosine kinase A2 (EphA2) |
| Immunogen | genetic immunisation with cDNA encoding human EphA2 |
| Format | Purified |
| Isotyp | IgG1 (Passende Sekundärantikörper) |
| Klon | Kalpha-5H5 |
| Beschreibung | EphA2 (Eph receptor tyrosine kinase A2) belongs to the Eph tyrosine receptor familiy, the largest receptor tyrosine kinase family of transmembrane proteins. It encodes a 130 kDA transmembrane protein which is primarily found in adult human epithelial cells (1). Eph receptors and their ephrin ligands are important mediators of cell-cell communication and play roles in embryonic patterning, neuronal targeting, and vascular development during normal embryogenesis (2,3). The Eph family of receptor tyrosine kinases is frequently overexpressed in a wide variety of cancers and tumor cell lines. In particular, EphA2 is overexpressed in prostate, lung and colon cancers and 40% of breast cancers and it represent an attractive potential target for drug design (3,4). |
| Spezifität | Anti-human EphA2 |
Anwendungen
| Applikationshinweise | FACS: 1.2ug/10^6 cells, Cell-ELISA: 1:200 to 1:400, Immunofluorescence: 1 ug/10^6 cells |
| Konzentration | 2 mg/ml |
| Reinigung | Protein G |
| Buffer | phosphate buffered saline, pH 7.2 |
| Lagerung | Short term: 2°C - 8°C. long term: -20°C (avoid repeated freezing and thawing) |
| Beschränkungen | Nur für Forschungszwecke einsetzbar |
Bilder
Publikationen
| Publikationen |
Lindberg, Hunter: "cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases." in: Molecular and cellular biology, Vol. 10, Issue 12, pp. 6316-24, 1991 (PubMed).
Nakamoto, Bergemann: "Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis." in: Microscopy research and technique, Vol. 59, Issue 1, pp. 58-67, 2002 (PubMed). Brantley-Sieders, Schmidt, Parker et al.: "Eph receptor tyrosine kinases in tumor and tumor microenvironment." in: Current pharmaceutical design, Vol. 10, Issue 27, pp. 3431-42, 2004 (PubMed). Ireton, Chen: "EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics." in: Current cancer drug targets, Vol. 5, Issue 3, pp. 149-57, 2005 (PubMed). |




